Heart drug halt tested for rare disease
NCT ID NCT05019027
Summary
This study is checking if older adults with a rare heart condition called cardiac amyloidosis feel better and can exercise more when they stop taking their beta-blocker medicine. Twenty participants will try two periods: one on their usual dose and one with the medicine slowly reduced or stopped. Researchers will measure exercise capacity and quality of life to see which approach works better for each person.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.